Influence of 5-Hydroxytryptamine, 5-Hydroxytryptophan. Dopamine, Norepinephrine, and Reserpine on Thrombotic Deposits in the Rabbit

Summary

5-hydroxytryptamine (5-HT, serotonin) and its precursor 5-hydroxytryptophan (5-HTP) significantly inhibit in rabbit blood vessels formation of thrombotic deposits, a term used by us to specify platelet aggregates on the intima ringed by leucocytes, resulting from intimai injury. Simultaneous inhibition of monoamine oxidase by Nialamide clearly enhances this action of 5-HT and 5-HTP. The marked activity of the combination of 5-HT + Nialamide is not limited to the initial phase of thrombogenesis, but is discernible at a weaker level 30 minutes and even as long as 24 hours after intimai injury. The monoamines dopamine and norepinephrine exert, as reserpine, no influence on the formation of thrombotic deposits.

These results underline the importance of 5-HT in the initial events of thrombogenesis. They support the hypothesis that inhibition of the formation of thrombotic deposits is in some manner related to an interaction between 5-HT, blood platelets and possibly vessel wall.

• References

• 1 Zahn W. F. Bildung der Thromben. Virchows Arch. path. Anat. 62: 81 1875;
• 2 Baumgartner H. R, Studer A, Reber K. Über Methoden zur Erzeugung experimenteller Thrombosen am Kaninchenohr und die Bedeutung von 5-Hydroxytryptamin bei deren Entstehung. Thrombos. Diathes. haemorrh. (Stuttg.) 9: 485 1963;
• 3 Bizzozero J. Über einen neuen Formbestandteil des Blutes und dessen Rolle bei der Thrombose und der Blutgerinnung. Virchows Arch. path. Anat. 90: 261 1882;
• 4 Honour A. J, Mitchell J. R. A. Platelet clumping in vivo. Nature (Lond.) 197: 1019 1963;
• 5 Honour A. J, Ross-Russell R. W. Experimental platelet embolism. Brit. J. exp. Path. 43: 350 1962;
• 6 Shimamoto T, Yamazaki H, Inoue M, Fujita T, Sagawa N, Sunaga T, Ishioka T. Discovery of antithromboembolic effect of Nialamide. Protection of “silicone-like property” of blood vessels by Nialamide. Proc. Japan. Acad. 36: 240 1960;
• 7 Bracco M, Curti P. C. The vasoconstrictor factor of platelets. Experientia (Basel) 10: 71 1954;
• 8 Ersparmer V. Pharmacology of indolealkylamines. Pharamcol. Rev. 6: 425 1954;
• 9 Zucker M. B, Friedman B. K, Rapport M. M. Identification and quantitative determination of serotonin (5-HT) in blood platelets. Proc. Soc. exp. Biol. (N. Y.) 85: 282 1954;
• 10 Pletscher A, Bernstein A. Increase of 5-hydroxytryptamine in blood platelets by isopropyl-isonicotinic acid hydrazide. Nature (Lond.) 181: 1133 1958;
• 11 Shore P. A, Gillespie L, Spector S, Prockop D. Increase in blood serotonin levels induced by iproniazid in man and rabbits. Naturwissenschaften 45: 340 1958;
• 12 Ersparmer V. Observations on the 5-HT (enteramine) release caused by reserpine in the rat. Experientia (Basel) 12: 63 1956;
• 13 Shore P. A, Pletscher A, Tomich E. G, Kuntzman R, Brodie B. B. Release of blood platelet serotonin by reserpine and lack of effect on bleeding time. J. Pharmacol, exp. Ther. 277: 232 1956;
• 14 Ersparmer V. Recent research in the field of 5-hydroxytryptamine and related indolealkylamines. Fort sehr. Arzneimittelforsch. 3: 151 1961;
• 15 Zucker M. B. Serotonin (5-hydroxytryptamine): Hematologic aspects. Progr. Hemat. 2: 206 1959;